Bioxcel Therapeutics, Inc.
BTAI
Revenue
1.10M
▲522.00k▲89.69%
3 Months ChangeAssets
65.44M
▼-16.89M▼-20.51%
3 Months ChangeLiabilities
139.74M
▼-14.95M▼-9.66%
3 Months ChangeFree Cash Flow
-32.53M
▼-12.58M▼-63.02%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-09
Form 8-K
ID: 0001104659-24-107327
2024-09-20
Form 8-K
ID: 0001104659-24-101689
2024-09-19
Form 8-K
ID: 0001104659-24-101176
2024-09-09
Form 8-K
ID: 0001104659-24-098149
2024-09-05
Form 8-K
ID: 0001104659-24-097127
2024-08-06
Form 10-Q
ID: 0001558370-24-010967
2024-08-06
Form 8-K
ID: 0001104659-24-086086
2024-07-17
Form 8-K
ID: 0001104659-24-080571
2024-07-16
Form 8-K
ID: 0001104659-24-080022
2024-06-25
Form 8-K
ID: 0001104659-24-074545